Düsseldorf, Germany — November 17–20, 2025
WEGO Medical made a strong appearance at MEDICA 2025, one of the world’s most influential medical industry exhibitions. Under the theme “WEGO, Innovating a Healthier Tomorrow,” the company showcased its eight core product lines, including medical consumables, blood purification solutions, and orthopedic implants. The booth attracted significant attention from international customers, distributors, and healthcare experts worldwide.
Deepening Global Engagement and Showcasing the Power of Chinese Innovation
Recognized as a global “barometer” for the medical industry, MEDICA 2025 brought together more than 5,000 exhibitors from over 130 countries and welcomed more than 80,000 professional visitors.
As a key platform in WEGO’s globalization strategy, WEGO Overseas presented a comprehensive portfolio of solutions, giving international partners a deeper understanding of the company’s capabilities. Throughout the four-day exhibition, the WEGO booth received visitors from Europe, the Middle East, Africa, and Latin America, many of whom expressed strong interest and initial intent for cooperation. These engagements provided solid momentum for WEGO’s continued expansion into global markets.
Innovative Products and Integrated Solutions Leading the Industry
At MEDICA 2025, WEGO Medical presented itself as a provider of integrated clinical solutions, showcasing a complete ecosystem that spans diagnosis, treatment, and post-care.
Eight Core Product Series Showcased
This integrated product layout fully reflects the vision presented at the WEGO Global Partners Conference 2025—“Gather Intelligence, Shape the Future.” By uniting expertise across multiple disciplines, WEGO provides comprehensive, efficient, and reliable solutions for global healthcare systems. This positioning marks WEGO’s evolution from a category specialist to a full-scope medical technology enterprise with extensive global service capabilities.
Accelerating Global Deployment and Expanding Market Presence
In recent years, WEGO Medical has pursued a strategy of accelerated global expansion, strengthening its presence through international exhibitions such as MEDICA, enhancing brand influence, and enabling deeper market penetration.
Diversified Market Development Strategy
WEGO Medical has developed a three-tier market development model, allowing the company to:
Deeply cultivate strategic markets
Strengthen operational and distribution markets
Rapidly enter emerging and blank markets
This structured approach ensures targeted resource allocation and balanced global expansion.
Advancing Localization
WEGO continues to strengthen its localization strategy by:
Recruiting international employees
Establishing overseas subsidiaries
Enhancing local service capabilities
This shift from simple product export to comprehensive market operations and localized presence marks a critical milestone in WEGO’s global transformation.
Leveraging MEDICA’s global stage, WEGO Medical not only demonstrated its breakthrough from “Made in China” to “Created in China,” but also deepened its dialogue with global partners, reinforcing the foundation of its international strategy.
Committed to Building a Healthier Future with Global Partners
Guided by WEGO Medical’s strategic direction, WEGO Medical will continue implementing its global development model of international trade, joint-venture manufacturing, strategic investments, and capital operations. As the company expands its global footprint, it is steadily progressing toward becoming a world-class medical technology enterprise.
With the WEGO Global Partners Conference 2026 approaching, WEGO looks forward to collaborating with partners worldwide to explore the future of smart healthcare and unlock new possibilities for global medical innovation.
